Cargando…
Whole-genome approach implicates CD44 in cellular resistance to carboplatin
Carboplatin is a chemotherapeutic agent used in the management of many cancers, yet treatment is limited by resistance and toxicities. To achieve a better understanding of the genetic contribution to carboplatin resistance or toxicities, lymphoblastoid cell lines from 34 large Centre d'Etude du...
Autores principales: | Shukla, Sunita J, Duan, Shiwei, Wu, Xiaolin, Badner, Judith A, Kasza, Kristen, Dolan, M Eileen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683878/ https://www.ncbi.nlm.nih.gov/pubmed/19164090 http://dx.doi.org/10.1186/1479-7364-3-2-128 |
Ejemplares similares
-
SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s
por: Shi, Lin, et al.
Publicado: (2019) -
Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016) -
Increased invasion and tumorigenicity capacity of CD44(+)/CD24(-) breast cancer MCF7 cells in vitro and in nude mice
por: Yan, Wenxing, et al.
Publicado: (2013) -
CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
por: Chang, Guoqiang, et al.
Publicado: (2013) -
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
por: Peng, Wei-zhao, et al.
Publicado: (2019)